HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a large smoking cessation market.
Latest Ratings for ACHV
DateFirmActionFromTo Oct 2021Alliance Global PartnersInitiates Coverage OnBuy Jun 2021OppenheimerInitiates Coverage OnOutperform Sep 2020Lake StreetInitiates Coverage OnBuy